Predicine’s Liquid Biopsy Next-Generation Sequencing (NGS) Assay is Granted Breakthrough Device Designation by U.S. Food and Drug Administration SILICON...
Predicine Appoints Clint Webb as New General Counsel to Support Its International Expansion SILICON VALLEY, Calif., Jan. 19, 2022 /PRNewswire/ — Predicine, a...
Predicine Appoints Dr. Dennis Merkle as New Chief Executive Officer SILICON VALLEY, Calif., Jan. 4, 2022 /PRNewswire/ — Predicine, a global molecular...
Results from the study utilizing the PredicineCARE liquid biopsy assay evaluate the concordance of somatic alterations identified by standard tissue...
Epic’s Comprehensive Cancer Profiling™ now includes the broadest ctDNA assay PredicineATLAS™ Predicine, a molecular insights company headquartered in Hayward,...
Predicine and Merck KGaA, Darmstadt, Germany collaboratively highlight the importance of multi-parametric profiling of ctDNA and cfRNA for holistic molecular...
Predicine is committed to supporting next-generation scientists in biomedical sciences. Through Predicine Translational Research Award at Harvard Medical School’s New...
Predicine today announced a strategic partnership with FMD to help biopharma companies accelerate biomarker-driven clinical trials and concurrent New Drug...
Predicine and Flagship Biosciences are excited to announce a strategic venture. The synergistic combination of Predicine’s GeneRADAR molecular insights platform...